Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

New oral treatment, finasteride, effectively and safely treats common hair loss.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Finasteride and minoxidil are the main effective treatments for hair loss from androgenetic alopecia.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Hair loss requires customized treatments based on its various causes and types.

10% minoxidil solution better promotes hair growth and reduces hair loss without significant side effects.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The document concludes that a high-protein, low-carb diet can lead to significant weight loss but requires caution and further research.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.